Thyroid gene variation may increase risk for Alzheimer's disease in African Americans

March 13, 2018, Rush University Medical Center

African Americans with a common genetic variation are at increased risk for developing Alzheimer's disease, while European Americans with the same variation are not, according to a study led by researchers at Rush University Medical Center. They published the study results in the February 22 online issue of the Journal of Clinical Endocrinology and Metabolism.

The , known as Thr92AlaD2 polymorphism, affects a gene involved in the activation of and occurs commonly; almost half the population are carriers of this polymorphism. The study found that African Americans with this polymorphism are 30 percent more likely to develop Alzheimer's disease dementia than the African American without the genetic polymorphism. Whereas in European Americans, this gene wasn't associated with increased risk of Alzheimer's. This is a remarkable juxtaposition.

"This correlation only shows up in African-Americans. We have some ideas but aren't sure why," said Elizabeth McAninch MD, study author and assistant professor of the Division of Endocrinology and Metabolism at Rush.

Discovery is twist in research that began with thyroid gland

The discovery was the latest twist in an investigation that began years ago in Rush's endocrinology division under the leadership of Dr. Antonio Bianco, a thyroid expert and the director of the present studies. Endocrinologists provide care for hormone imbalances that cause health problems.

The Thr92AlaD2 polymorphism affects an enzyme that activates thyroid hormones. The enzyme is most important when considering patients with a condition known as hypothyroidism, which occurs when there is insufficient thyroid hormone being produced by the . In most cases, this condition can be controlled with the standard treatment for hypothyroidism, a drug called levothyroxine. However, about 15 percent of patients treated with levothyroxine consistently say it doesn't help them feel better.

Wondering what was behind those reports, McAninch and colleagues at Rush previously obtained and analyzed brain tissue from the University of Miami Brain Bank from deceased Caucasian male organ donors who at their time of death were young and healthy, without known thyroid problems, to see if they could find any clues. To their surprise, the brains of the healthy donors who had the polymorphism displayed biomarkers that are known to play a role in neurodegenerative brain disease.

"This was a shock to us and deserved more investigation," McAninch recalled.

Researchers then drew on data from long-term studies of Alzheimer's

The endocrinologists then enlisted the help of Rush researchers who specialize in the issues of the aging brain, and the expanded team set to work with data from three long-term group studies done at Rush from 1993 to 2012—the Chicago Health and Aging Project (CHAP), the Religious Orders Study (ROS), and the Rush Memory and Aging Project (MAP).

The CHAP cohort includes 3656 participants, 2321 of whom are African American, who received cognitive testing in three-year cycles for more than 18 years. In ROS and MAP, 1,707 European American participants without known dementia were enrolled and had annual evaluations.

Again, McAninch and colleagues also continued to collaborate with the University of Miami Brain Bank to obtain and study brain tissue from young, healthy African American donors.

Through utilizing the CHAP data, which has both African American and European American participants, this unique racially-stratified outcome revealed itself. "That's when we saw this huge discrepancy in risk for Alzheimer's disease dementia," McAninch said.

Questions remain to be answered in future studies

Minorities tend to be understudied in medical research in general, and specifically there needs to be more, larger studies of African Americans to evaluate the risk of Alzheimer's, McAninch observed. "A strength of this study is credited to the amazing resource we have in these three cohort studies here at Rush, where we were able to look at the differences between African-Americans and European-Americans," she says.

The Rush-led team is already planning the next inquiry, McAninch says, "to try to understand why African-Americans have this risk, while the European-Americans do not."

Explore further: Alzheimer's may affect the brain differently in African-Americans than European-Americans

Related Stories

Alzheimer's may affect the brain differently in African-Americans than European-Americans

July 15, 2015
Alzheimer's disease may cause different changes in the brain, or pathologies, in African-Americans than in white Americans of European descent, according to a study published in the July 15, 2015, online issue of the medical ...

New study to document Alzheimer's disease risk factors in Latinos

February 22, 2017
Rush University Medical Center has launched a unique, cohort study called Latino Core to learn about the aging process and risk factors for Alzheimer's disease in older Latino adults.

New insights into treatment of hypothyroidism

January 12, 2015
An international research team led by physician-scientists at Rush University Medical Center have gained new insights into hypothyroidism – a condition affecting about 10 million people in the U.S. – that may lead to ...

Researchers gain new insights into hypothyroidism

January 27, 2015
An international research team led by physician-scientists at Rush University Medical Center has gained new insights into hypothyroidism - a condition affecting about 10 million people in the U.S. - that may lead to new treatment ...

Alzheimer's disease may be more prevalent and manifests itself differently among African-Americans

April 7, 2014
A new study by researchers at Rush University Medical Center reviews research that suggests that the risk for developing Alzheimer's disease among older African Americans may be two to three times greater than in the non-Hispanic ...

Abnormal brain protein may contribute to Alzheimer's disease development

September 30, 2016
A recently-recognized pathologic protein in the brain may play a larger role in the development of clinical Alzheimer's disease dementia than previously recognized, according to a study by researchers at Rush University Medical ...

Recommended for you

Recent clinical trial finds tamsulosin not effective in kidney stone passage

June 18, 2018
The latest research into finding medications to aid the passage of ureteral or kidney stones has shown that tamsulosin is not effective for patients across the board. Previously approved to help men experiencing enlarged ...

Research finds new way to determine protection of Men B vaccine against different strains

June 18, 2018
Researchers at the University of Leicester and Meningococcal Reference Unit have developed a new approach to assess the effectiveness of the Men B vaccine, Bexsero, against different strains that cause meningococcal meningitis ...

Novel molecular target to prevent scarring of the lung blood vessels identified

June 13, 2018
Pulmonary arterial hypertension, a severe form of cardiopulmonary disease in which the arteries that transport blood from the heart to the lungs become thickened, constricted, and scarred, is a disease for which there is ...

Lineage of TB traced and compared to early human migration

June 13, 2018
A team of researchers from the University of Wisconsin, the University of Iowa and the Norwegian Institute of Public Health has carried out genetic studies of tuberculosis to learn more about its lineage and to compare it ...

Fast-acting cholera vaccine could curb outbreaks

June 13, 2018
A tricked-out cholera vaccine starts protecting against the deadly disease within a day, experiments in rabbits suggest. The rapid protection offered by this designer vaccine may one day limit the spread of cholera outbreaks, ...

Finally, hope for a syphilis vaccine

June 12, 2018
Despite efforts to eradicate it, syphilis is on the rise. Until now, most health agencies focused on treating infected people and their sex partners but new discoveries may make a vaccine possible, UConn Health researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.